134 related articles for article (PubMed ID: 17311949)
1. Synthesis, characterization, and bioavailability in rats of ferric phosphate nanoparticles.
Rohner F; Ernst FO; Arnold M; Hilbe M; Biebinger R; Ehrensperger F; Pratsinis SE; Langhans W; Hurrell RF; Zimmermann MB
J Nutr; 2007 Mar; 137(3):614-9. PubMed ID: 17311949
[TBL] [Abstract][Full Text] [Related]
2. Particle Size, Surface Area, and Amorphous Content as Predictors of Solubility and Bioavailability for Five Commercial Sources of Ferric Orthophosphate in Ready-To-Eat Cereal.
Dickmann RS; Strasburg GM; Romsos DR; Wilson LA; Lai GH; Huang H
Nutrients; 2016 Mar; 8(3):129. PubMed ID: 26938556
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Mg and Ca into nanostructured Fe2O3 improves Fe solubility in dilute acid and sensory characteristics in foods.
Hilty FM; Knijnenburg JT; Teleki A; Krumeich F; Hurrell RF; Pratsinis SE; Zimmermann MB
J Food Sci; 2011; 76(1):N2-10. PubMed ID: 21535701
[TBL] [Abstract][Full Text] [Related]
4. Does ascorbic acid supplementation affect iron bioavailability in rats fed micronized dispersible ferric pyrophosphate fortified fruit juice?
Haro-Vicente JF; Pérez-Conesa D; Rincón F; Ros G; Martínez-Graciá C; Vidal ML
Eur J Nutr; 2008 Dec; 47(8):470-8. PubMed ID: 18953478
[TBL] [Abstract][Full Text] [Related]
5. Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation.
Hilty FM; Arnold M; Hilbe M; Teleki A; Knijnenburg JT; Ehrensperger F; Hurrell RF; Pratsinis SE; Langhans W; Zimmermann MB
Nat Nanotechnol; 2010 May; 5(5):374-80. PubMed ID: 20418865
[TBL] [Abstract][Full Text] [Related]
6. Iron from nanostructured ferric phosphate: absorption and biodistribution in mice and bioavailability in iron deficient anemic women.
Baumgartner J; Winkler HC; Zandberg L; Tuntipopipat S; Mankong P; Bester C; Hilty F; Zeevaart JR; Gowachirapant S; Zimmermann MB
Sci Rep; 2022 Feb; 12(1):2792. PubMed ID: 35181698
[TBL] [Abstract][Full Text] [Related]
7. Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats.
Wegmüller R; Zimmermann MB; Moretti D; Arnold M; Langhans W; Hurrell RF
J Nutr; 2004 Dec; 134(12):3301-4. PubMed ID: 15570029
[TBL] [Abstract][Full Text] [Related]
8. Acute toxicity of carbonyl iron and sodium iron EDTA compared with ferrous sulfate in young rats.
Whittaker P; Ali SF; Imam SZ; Dunkel VC
Regul Toxicol Pharmacol; 2002 Dec; 36(3):280-6. PubMed ID: 12473412
[TBL] [Abstract][Full Text] [Related]
9. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
[TBL] [Abstract][Full Text] [Related]
10. A comparison of physical properties, screening procedures and a human efficacy trial for predicting the bioavailability of commercial elemental iron powders used for food fortification.
Lynch SR; Bothwell T;
Int J Vitam Nutr Res; 2007 Mar; 77(2):107-24. PubMed ID: 17896584
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of elemental iron powders to rats is less than bakery-grade ferrous sulfate and predicted by iron solubility and particle surface area.
Swain JH; Newman SM; Hunt JR
J Nutr; 2003 Nov; 133(11):3546-52. PubMed ID: 14608072
[TBL] [Abstract][Full Text] [Related]
12. Development and optimization of iron- and zinc-containing nanostructured powders for nutritional applications.
Hilty FM; Teleki A; Krumeich F; Büchel R; Hurrell RF; Pratsinis SE; Zimmermann MB
Nanotechnology; 2009 Nov; 20(47):475101. PubMed ID: 19875869
[TBL] [Abstract][Full Text] [Related]
13.
Garcia-Fernandez J; Turiel D; Bettmer J; Jakubowski N; Panne U; Rivas García L; Llopis J; Sánchez González C; Montes-Bayón M
Nanotoxicology; 2020 Apr; 14(3):388-403. PubMed ID: 31958026
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals.
Zimmermann MB; Biebinger R; Egli I; Zeder C; Hurrell RF
Br J Nutr; 2011 Apr; 105(8):1245-50. PubMed ID: 21205385
[TBL] [Abstract][Full Text] [Related]
15. Stabilized-solubilized ferric pyrophosphate as a new iron source for food fortification. Bioavailability studies by means of the prophylactic-preventive method in rats.
Salgueiro MJ; Arnoldi S; Kaliski MA; Torti H; Messeri E; Weill R; Zubillaga M; Boccio J
Biol Trace Elem Res; 2009 Feb; 127(2):143-7. PubMed ID: 18802669
[TBL] [Abstract][Full Text] [Related]
16. Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate.
Sakaguchi N; Rao TP; Nakata K; Nanbu H; Juneja LR
Int J Vitam Nutr Res; 2004 Jan; 74(1):3-9. PubMed ID: 15060895
[TBL] [Abstract][Full Text] [Related]
17. Iron derivatives from casein hydrolysates as a potential source in the treatment of iron deficiency.
Chaud MV; Izumi C; Nahaal Z; Shuhama T; Bianchi Mde L; de Freitas O
J Agric Food Chem; 2002 Feb; 50(4):871-7. PubMed ID: 11829660
[TBL] [Abstract][Full Text] [Related]
18. Comparison of micro- and nanoscale Fe⁺³-containing (Hematite) particles for their toxicological properties in human lung cells in vitro.
Bhattacharya K; Hoffmann E; Schins RF; Boertz J; Prantl EM; Alink GM; Byrne HJ; Kuhlbusch TA; Rahman Q; Wiggers H; Schulz C; Dopp E
Toxicol Sci; 2012 Mar; 126(1):173-82. PubMed ID: 22262566
[TBL] [Abstract][Full Text] [Related]
19. Iron bioavailability of cocoa powder as determined by the Hb regeneration efficiency method.
Yokoi K; Konomi A; Otagi M
Br J Nutr; 2009 Jul; 102(2):215-20. PubMed ID: 19102811
[TBL] [Abstract][Full Text] [Related]
20. One-Pot Facile Fabrication of Bioavailable Iron Nanoparticles with Good Biocompatibility for Anemia Therapy.
Gu Y; Li Y; Yang Y; Luo Q; Zhang Y; Zhou C
Med Sci Monit; 2018 Sep; 24():6449-6455. PubMed ID: 30215387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
